Study Indication Stratified by Serum PSA Level
| Indication | 0.2−5.0 ng/mL | 5.1–10.0 ng/mL | 10.1–20.0 ng/mL | >20.1 ng/mL |
| Initial staging (n = 93) | 12 (13%) | 26 (28%) | 22 (24%) | 33 (35%) |
| Biochemical recurrence localization (n = 225) | 175 (78%) | 28 (12%) | 17 (8%) | 5 (2%) |
| Restaging M1 disease (n = 70) | 29 (41%) | 10 (14%) | 11 (16%) | 20 (29%) |